The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.28, Iss.5, 2012-05, pp. : 365-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study

By Elnashar Aboubakr Abdelmageed Emad Fayed Mahmod Sharaf Magdy

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1805-1808

Oxford University Press

Access to resources Recommend Favorite

Sequential treatment of metformin and clomiphene citrate in clomiphene‐resistant women with polycystic ovary syndrome: a randomized, controlled trial

By George Susan Shanti

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 299-304

Oxford University Press

Access to resources Recommend Favorite

Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome

By van Wely Madelon

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 900-905

Oxford University Press

Access to resources Recommend Favorite

Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome

By Sönmez A.S.

Human Reproduction, Vol. 20, Iss. 1, 2005-01 ,pp. : 175-179

Oxford University Press

Access to resources Recommend Favorite

Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?

By Palomba Stefano

Human Reproduction, Vol. 19, Iss. 11, 2004-11 ,pp. : 2682-2683

Oxford University Press

Access to resources Recommend Favorite